Trial Profile
Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- 28 Nov 2015 Status changed from active, no longer recruiting to completed according to results published in the European Journal of Obstetrics and Gynecology and Reproductive Biology
- 09 May 2012 New trial record